Advanced search
Publication Cover
Neuro-Ophthalmology Volume 45, 2021 - Issue 1
Submit an article Journal homepage
113
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Corticosteroid Usage in Giant Cell Arteritis

Amritha Kanakamedalaa School of Medicine, Baylor University College of Medicine, Houston, Texas, USAORCID Iconhttps://orcid.org/0000-0002-3437-6079
ORCID Icon,
Mariam Hussainb School of Medicine, Texas A & M University College of Medicine, Bryan, Texas, USA
,
Ashwini Kinic Department of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital, Houston, Texas, USAORCID Iconhttps://orcid.org/0000-0001-6313-2885
ORCID Icon,
Bayan Al Othmanc Department of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital, Houston, Texas, USAORCID Iconhttps://orcid.org/0000-0001-9085-2079
ORCID Icon &
Andrew G. Leec Department of Ophthalmology, Blanton Eye Institute, Houston Methodist Hospital, Houston, Texas, USA;d Departments of Ophthalmology, Neurology, and Neurosurgery, Weill Cornell Graduate School of Medical Sciences, Cornell University, New York, New York, USA;e Department of Ophthalmology, University of Texas Medical Branch, Galveston, Texas, USA;f Department of Ophthalmology, University of Texas MD Anderson Cancer Center, Houston, Texas, USA;g Department of Ophthalmology, Texas A & M University College of Medicine, Bryan, Texas, USA;h Department of Ophthalmology, The University of Iowa Hospitals and Clinics, Iowa City, Iowa, USACorrespondence[email protected]
Pages 17-22 | Received 18 Mar 2020, Accepted 07 May 2020, Published online: 16 Jul 2020

References

  • Cho HJ, Bloomberg J, Nichols J. Giant cell arteritis. Dis Mon. 2017;63(3):88–91. doi:10.1016/j.disamonth.2016.10.006.
  • Manzo C, Milchert M. Polymyalgia rheumatica with normal values of both erythrocyte sedimentation rate and C-reactive protein concentration at the time of diagnosis: a four-point guidance. Reumatologia. 2018;56:1–2.
  • Fraser JA, Weyand CM, Newman NJ, Biousse V. The treatment of giant cell arteritis. Rev Neurol Dis. 2008;5:140–152.
  • Aiello PD, Trautmann JC, McPhee TJ, Kunselman AR, Hunder GG. Visual prognosis in giant cell arteritis. Ophthalmology. 1993;100:550–555.
  • Mackie SL, Dejaco C, Appenzeller S, et al. British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis: executive summary. Rheumatology (Oxford). 2020;59:e1e23.
  • Almarzouqi SJ, Morgan ML, Lee AG. Treatment of giant cell arteritis. Curr Opin Ophthalmol. 2015;26:469–475.
  • Baig IF, Pascoe AR, Kini A, Lee AG. Giant cell arteritis: early diagnosis is key. Eye Brain. 2019;11:1–12.
  • Buttgereit F, Dejaco C, Matteson EL, Dasgupta B. Polymyalgia rheumatica and giant cell arteritis: a systematic review. JAMA. 2016;315:2442–2458.
  • Pioro MH. Primary care vasculitis: polymyalgia rheumatica and giant cell arteritis. Prim Care. 2018;45:305–323.
  • Danesh-Meyer HV, Savino PJ. Giant cell arteritis. Curr Opin Ophthalmol. 2007;18(6):443–449. doi:10.1097/ICU.0b013e3282f0b4a9.
  • Chan CC, O’Day J. Oral and intravenous steroids in giant cell arteritis. Clin Exp Ophthalmol. 2003;31(3):179–182. doi:10.1046/j.1442-9071.2003.00643.x.
  • Winkler A, True D. Giant cell arteritis: 2018 review. Mo Med. 2018;115:468–470.
  • Nesher G, Breuer GS. Giant cell arteritis and polymyalgia rheumatica: 2016 update. Rambam Maimonides Med J. 2016;7(4):4. doi:10.5041/RMMJ.10262.
  • Kyle V, Hazleman BL. Treatment of polymyalgia rheumatica and giant cell arteritis. II. Relation between steroid dose and steroid associated side effects. Ann Rheum Dis. 1989;48:662–666.
  • V B. What’s hot in the treatment of giant cell arteritis. Paper presented at: North American Neuro-ophthalmology Society Annual Meeting, Snowbird, Utah; 2013.
  • Hayreh SS, Zimmerman B. Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies. Ophthalmologica. 2003;217:239–259.
  • Hayreh SS, Zimmerman B, Kardon RH. Visual improvement with corticosteroid therapy in giant cell arteritis. Report of a large study and review of literature. Acta Ophthalmol Scand. 2002;80:355–367.
  • Salvarani C, Cantini F, Boiardi L, Hunder GG. Polymyalgia rheumatica and giant-cell arteritis. N Engl J Med. 2002;347:261–271.
  • Chevalet P, Barrier JH, Pottier P, et al. A randomized, multicenter, controlled trial using intravenous pulses of methylprednisolone in the initial treatment of simple forms of giant cell arteritis: a one year followup study of 164 patients. J Rheumatol. 2000;27:1484–1491.
  • Cunningham CT, Quan H, Hemmelgarn B, et al. Exploring physician specialist response rates to web-based surveys. BMC Med Res Methodol. 2015;15:32.
  • Kellerman SE, Herold J. Physician response to surveys. A review of the literature. Am J Prev Med. 2001;20:61–67.
  • Keating NL, Zaslavsky AM, Goldstein J, West DW, Ayanian JZ. Randomized trial of $20 versus $50 incentives to increase physician survey response rates. Med Care. 2008;46:878–881.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.